Skip to main content
. 2019 Apr 12;7(4):E600–E607. doi: 10.1055/a-0867-9599

Table 2. Procedural and outcomes data.

Stent Placement
Successful EUS-HE (n = 53) Unsuccessful EUS-HE (n = 7) All procedures (n = 60)
Mean procedure time, minutes (SD) 117.11 (± 56.31) 134 (± 102.2) 117.11 (± 56.04)
Mean number of EUS-guided needle puncture attempts (SD)   1.04 (± 0.19)   1.43 (± 0.79)   1.04 (± 0.19)
Proximal stent site

  • Stomach

  46   7  53

  • Jejunum

   4   0   4

  • Esophagus

   3   0   3
Distal stent site

  • Left intrahepatic duct

  51

  • Biloma communicating with left intrahepatic duct

   1

  • Abscess communicating with left intrahepatic duct

   1
Mean size of left hepatic duct, mm (SD)   7.26 (± 3.63)   1.75 (± 2.58)   7.26 (± 3.61)
Mean dilation diameter prior to stent deployment (SD)   4.54 (± 1.03)   5 (± 1.41)   4.54 (± 1.03)
Cases requiring electrocautery   3   1   4
Stent diameters

  • 8 mm

  41

  • 10 mm

  12
Stent lengths

  • 40 mm

   2

  • 60 mm

   9

  • 80 mm

  31

  • 100 mm

  11
Median stent length, mm  80
Median stent diameter, mm   8
Cases requiring two overlapping stents   2
ERCP and Antegrade Therapy
Successful EUS-HG (n = 53) Unsuccessful EUS-HG (n = 7) All Procedures (n = 60)
Cases with ERC performed through EUS-HG (%)  43 (81.1 %)
Stricture present on ERCP  29
Type of stricture

  • Benign

  15

  • Malignant

  13

  • Indeterminant

   1
Mean number of procedures to resolution of condition (SD)   2.43 (± 1.01)
Clinical Outcome
Successful EUS-HE (n = 53) Unsuccessful EUS-HE (n = 7) All Procedures (n = 60)
Inpatient cases (%)  24 (45.3 %)   1 (14.3 %)  25 (41.7 %)
Outpatients admitted following procedure (%)  14 (26.4 %)   5 (71.4 %)  19 (31.7 %)
Outpatients discharged to home (%)  15 (28.3 %)   0 (0 %)  15 (25 %)
Mean reduction in bilirubin after procedure (SD)   2.35 (± 2.67)  –1.38 (± 3.69)   1.93 (± 2.58)
Patients with eventual stent removal (%)  27 (50.9 %)
Mean length of time stent left in place (SD)  97.67 (± 85.72)
Patients with clinical success (%)  53 (100 %)   4 (57.1 %)  57 (95 %)
Mean length of hospital stay after procedure (SD)   2.28 (± 4.12)   1.67 (± 2.42)   2.28 (± 4.12)
Patients with adverse events (%)   7 (13 %)   2 (28.6 %)   9 (15 %)
Severity of adverse events

  • Mild

   4   0   4

  • Moderate

   4   0   4

  • Severe

   0   3   3
Patients with unplanned surgical intervention (%)   3 (5.66 %)   3 (42.9 %)   6 (10 %)
Deaths during follow up from underlying malignancy (%)   4 (7.55 %)   1 (14.3 %)   5 (8.3 %)

EUS-HE, endoscopic ultrasound-guided hepaticoenterostomy